Boosting Domestic Drug Production for US Security
This act aims to reduce US reliance on foreign suppliers for pharmaceutical ingredients. It establishes a pilot program to evaluate new domestic drug manufacturing technologies. This initiative could lead to greater security in access to essential medicines for citizens, especially during crises.
Key points
A pilot program will develop domestic production of key drug ingredients, enhancing supply security.
Reduced reliance on foreign drug manufacturers may lead to more stable prices and availability of important medications.
Expired
Citizen Poll